Abstract: Oral, topical and injectable contraceptives, which are based on sperm protein 22 kDa (SP22) polypeptides and antibodies and infertility diagnostics are provided.
Type:
Grant
Filed:
July 22, 2004
Date of Patent:
May 1, 2007
Assignee:
United States of America The U.S. Environmental Protection Agency